 Cost Effectiveness: Site-level cost studies of HIV care services have shown that human resource costs are a major determination of treatment scale-up costs and, as such, support the recommendations for task-shifting.51-53 Despite this, only a few cost and cost-effectiveness studies have assessed alternative ART-delivery models.54-59 